Clinical Trial Update: Effect of Potassium and Acetazolamide on People With Andersen-Tawil Syndrome [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial investigating the effects of potassium and acetazolamide in people with Andersen-Tawil syndrome was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Andersen-tawil Syndrome

Drugs mentioned

• ACETAZOLAMIDE (acetazolamide)
• Potassium (Potassium)

Snippet

Sponsor: University of Rochester | Conditions: Andersen-Tawil Syndrome | Phase 1 | Status: TERMINATED